POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 57 filers reported holding POSEIDA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $79,125 | -71.2% | 33,246 | -78.7% | 0.00% | – |
| Q2 2023 | $274,498 | -67.6% | 155,965 | -43.2% | 0.00% | – |
| Q1 2023 | $846,088 | +82.6% | 274,704 | +214.3% | 0.00% | – |
| Q4 2022 | $463,289 | -64.9% | 87,413 | -76.6% | 0.00% | – |
| Q3 2022 | $1,320,000 | +605.9% | 374,138 | +415.5% | 0.00% | – |
| Q2 2022 | $187,000 | +47.2% | 72,574 | +156.1% | 0.00% | – |
| Q1 2022 | $127,000 | -25.3% | 28,337 | +13.3% | 0.00% | – |
| Q4 2021 | $170,000 | +107.3% | 25,014 | +121.4% | 0.00% | – |
| Q3 2021 | $82,000 | -60.6% | 11,300 | -45.4% | 0.00% | – |
| Q2 2021 | $208,000 | -85.3% | 20,710 | -86.1% | 0.00% | – |
| Q1 2021 | $1,419,000 | +259.2% | 148,658 | +234.0% | 0.00% | – |
| Q3 2020 | $395,000 | – | 44,515 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $2,692,000 | 1.92% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 380,606 | $982,000 | 0.30% |
| Pentwater Capital Management LP | 4,967,227 | $12,815,000 | 0.15% |
| Atom Investors LP | 55,827 | $144,000 | 0.06% |
| Corton Capital Inc. | 14,978 | $39,000 | 0.04% |
| Forefront Analytics, LLC | 23,370 | $61,000 | 0.03% |
| Delphia (USA) Inc. | 15,799 | $41,000 | 0.03% |
| Advisory Services Network, LLC | 259,571 | $670,000 | 0.02% |
| Laurion Capital Management LP | 545,700 | $1,408,000 | 0.02% |
| MCF Advisors LLC | 59,659 | $154,000 | 0.02% |